It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
As one of the preconditions to authorizing close to $300 million in aid, the United States is pressuring El Salvador to purchase genetically modified seeds from Monsanto instead of non-GM seeds from local farmers.
According to Sustainable Pulse, a website covering developments related to genetically modified organisms and sustainable agriculture, the US will reportedly withhold $277 million in aid through the Millennium Challenge Compact if El Salvador refuses to purchase GM seeds from the biotech company Monsanto.
The website states that the stalled aid package was originally put on hold in late 2013, when it was revealed that Millennium Challenge Corporation would not deliver funds to the country unless “specific” economic and environmental reforms were made. Apparently, one of those is related to the purchase of GMO seeds.
Speaking with Verdad Digital, however, the president of the El Salvadoran Center for Appropriate Technologies (CESTA) criticized the US negotiating position and said the country should back away from its demand.
“I would like to tell the U.S. Ambassador to stop pressuring the Government (of El Salvador) to buy ‘improved’ GM seeds,” CESTA president Ricardo Navarro said, adding that the move would hurt the local economy and only benefit US companies.
Navarro specifically singled out Monsanto for criticism as well, saying, “There is a harmful corporation on the planet called Monsanto … it is truly disturbing that the U.S. is trying to promote them.”
This is another example of how corporations, especially Monsanto, influence US policies both domestically and abroad. - See more at: www.abovetopsecret.com...
Syngenta AG is a global Swiss agribusiness that markets seeds and agrochemicals. Syngenta is involved in biotechnology and genomic research. It was formed in 2000 by the merger of Novartis Agribusiness and Zeneca Agrochemicals. The company was ranked third in total seeds and biotechnology sales in 2009 in the commercial market. Sales in 2013 were approximately US$ 14.7 billion. Syngenta employs over 28,000 people in over 90 countries. Over half of the sales are in Emerging Markets. Syngenta is listed on both the Swiss stock exchange and in New York.